Dissolution testing is an important aspect of drug development as it provides stability parameters and helps predict drug behavior in-vivo. Kadmy/stock.adobe.com Dissolution testing is an important ...

When it comes to dissolution testing, research is focusing on ways to extend its reach, improve in-vitro and in-vivo correlation, and make real-time release testing a reality. Studying how a drug ...

The Pharmaceutical Dissolution Testing Services Market is poised for significant growth, with a projected market value of US$1.53 billion by 2033. This surge represents a substantial increase from the ...

The global Pharmaceutical Dissolution Testing Services Market is anticipated to reach US$ 693.12 Million in 2023 and US$ 1,538.48 Million by 2033, with a CAGR of 8.3% from 2023 to 2033. The expansion ...

(MENAFN- Market Press Release) March 29, 2023 2:58 am - More recently, CD Formulation announced to broaden its service range to tablet fragility test, dissolution test, and disintegration test.

New York, NY, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Polaris Market Research has published a new research report titled “Pharmaceutical Dissolution Testing Services Market Share, Size, Trends, Industry ...

NEWARK, Del, Dec. 13, 2022 (GLOBE NEWSWIRE) -- During the forecast period 2023-2033, the pharmaceutical dissolution testing services market is expected to grow at a value of 8.3% CAGR, according to ...

In addition to use of dissolution testers, this three-day course will also cover equipment qualification, development and validation of dissolution procedures, and the use of dissolution testing in ...

In the manufacture of solid dosage forms, the rate at which the active pharmaceutical ingredient (API) is dissolved into solvents simulating the digestive tract fluids is determined with dissolution ...

The British Pharmacopoeia on Monday released its response to its consultation on dissolution testing and announced its plans to update its approach within its product monographs. The British ...

Teva is voluntarily recalling a single lot of Anagrelide Capsules, USP 0.5mg, due to dissolution failure that was detected during a routine stability test. Teva is voluntarily recalling a single lot ...